ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 238

Inevitable Deterioration? Trajectories and Risk Profiles of Pain in Patients with Radiographic, Symptomatic Knee Osteoarthritis

Jamie E. Collins1, William M. Reichmann2, Jeffrey N. Katz3 and Elena Losina1, 1Orthopaedic and Arthritis Center for Outcomes Research, Brigham and Women's Hospital, Boston, MA, 2Orthopedics, Brigham and Womens Hospital, Boston, MA, 3Rheumatology and Orthopedics, Brigham and Women's Hospital, Boston, MA

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Knee, osteoarthritis and pain

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Osteoarthritis - Clinical Aspects

Session Type: Abstract Submissions (ACR)

Background/Purpose: Knee pain is the primary reason that patients with OA seek medical care. The goal of this study is to describe pain trajectory over three years in a cohort of patients with radiographic, symptomatic knee OA.

Methods: We used data from the Osteoarthritis Initiative (OAI), a multi-center, longitudinal, prospective observational study of knee OA. Pain assessments were done at baseline and at yearly visits for 4 years. We defined patients with symptomatic knee OA as those with central reader Kellgren/Lawrence (KL) score >2 and a WOMAC pain score >0. We used group-based trajectory modeling to identify distinct patterns of pain progression. To minimize the impact of baseline flare effect we restricted our analysis to visits occurring in months 12 through 48. We also built multivariable generalized linear models to determine factors affecting change in pain severity over time. Factors examined included sex, race, education, baseline comorbidities, 12-month age, BMI, alignment, KL grade, and depression.

Results: We used the data from 1,447 OAI study participants with radiographic, symptomatic knee OA at month 12. The average WOMAC pain at month 12 was 24 (0-100 scale with 100 = worst) with standard deviation 17.6. Individual pain reports varied markedly over time. For example, at 48 months, 51% reported a lower pain score than at 12 months and 36% reported a higher score. Also, 32% of all patients reported having no pain at one or more subsequent follow-up visits. Group based trajectory modeling identified 4 distinct pain trajectories [Figure]. Two-thirds of patients (groups 2 and 3 in Figure) started with moderate pain and showed little change on average over three years. The 12.6% in the highest pain trajectory tended to increase in pain by an average of 6 points over 3 years of follow-up, while patients in the first category (lowest pain at 12 months) decreased by an average of 9 points. Higher BMI, depression, and KL grade at the beginning of observation were associated with pain worsening over time in multivariable models.

Conclusion: We found that knee pain is highly variable over time and that pain neither worsens nor improves, on average, over three years in a majority of patients. Just 12.6% of patients demonstrate progressive worsening. These observations of highly variable pain reports with relatively little change on average over time contrast with the frequent clinical teaching that osteoarthritis symptoms progressively worsen over time.

 


Disclosure:

J. E. Collins,
None;

W. M. Reichmann,
None;

J. N. Katz,
None;

E. Losina,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/inevitable-deterioration-trajectories-and-risk-profiles-of-pain-in-patients-with-radiographic-symptomatic-knee-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology